Lindian Resources' Kangankunde Project on track for 2026 first production
Lindian Resources' (ASX:LIN) Kangankunde Rare Earths Project remains on track for its debut, with construction advancing towards a Q4 2026 first production target.
Mahathir Bayena
Crypto JournalistCrypto journalist for Grafa, with nearly 10 years of experience covering blockchain, Web3, and NFT gaming trends. MBA & Economics grad.
Contact
Contact editorial teamArticles by Mahathir Bayena
Hoskinson says AI agents threaten Big Tech
Charles Hoskinson said AI agents could become more relevant than humans online within the next decade, fundamentally disrupting the business models of major technology companies.
Agriculture
Vital Farms to exit butter business as egg oversupply triggers Q1 loss
Vital Farms (NASDAQ:VITL) reported a sharp reversal in profitability for the first quarter of 2026, prompting a significant restructuring of its product portfolio and a reduction in its full-year outlook.
Auto and cars
Cars.com returns to profitability in Q1 as cost-cutting measures take hold
Cars.com (NYSE:CARS) delivered a solid start to 2026, highlighted by a return to GAAP profitability and a significant expansion in its commitment to shareholder returns.
International Seaways declares record dividend as Q1 profit hits $286M
International Seaways (NYSE:INSW) reported a highly profitable first quarter for 2026, characterized by record shareholder returns and significant progress in its fleet modernization strategy.
Entertainment
Planet Fitness revenue skyrockets 22% as membership surpasses 21.5 million
Planet Fitness (NYSE:PLNT) reported strong top-line growth for the first quarter of 2026, though management struck a cautious tone by lowering full-year expectations and halting a planned pricing adjustment.
Insurance
Walker & Dunlop transaction volume surges 94% as commercial real estate activity rebounds
Walker & Dunlop (NYSE:WD) reported an explosive start to 2026, characterized by a dramatic recovery in deal flow and a significant expansion of its servicing portfolio.
-640x359.webp&w=3840&q=75)
Oculis secures FDA special protocol assessment for Phase 3 trial of optic neuritis treatment
Oculis Holding (NASDAQ:OCS) has received a Special Protocol Assessment (SPA) from the U.S. Food and Drug Administration (FDA) for its Phase 3 PIONEER-1 trial.
Pharming Group reaffirms 2026 guidance despite RUCONEST inventory drawdown
Pharming Group (NASDAQ:PHAR) reported first-quarter 2026 results that reflect a strategic transition toward its new growth engine, Joenja, while navigating anticipated headwinds in its legacy portfolio.
Retail
Super Retail Group hikes FY26 costs as sales stall
Super Retail Group (ASX:SUL) has adjusted its fiscal outlook, raising expected group and unallocated costs for FY26 by $6 million to a total of $66 million.